Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
88 hedge funds and large institutions have $97.1M invested in Gritstone bio, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 32 reducing their positions, and 14 closing their positions.
190% more call options, than puts
Call options by funds: $776K | Put options by funds: $268K
16% more capital invested
Capital invested by funds: $83.6M → $97.1M (+$13.5M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
1% less funds holding
Funds holding: 89 → 88 (-1)
34% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$16.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.07M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$654K |
| 4 |
Jane Street
New York
|
+$367K |
| 5 |
State Street
Boston,
Massachusetts
|
+$337K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$4.81M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$4.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.56M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.51M |
| 5 |
Millennium Management
New York
|
-$2.26M |
GRTS Hedge Fund Activity: Q4 2023 in Review
88 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2023, worth a combined $97.1M — up 16% from $83.6M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of GRTS and 13 opened new positions — a net loss of 1 holder — while 32 trimmed existing stakes and 21 added.
The largest buyer was Morgan Stanley, adding an estimated $16.9M. The largest seller was Redmile Group, cutting an estimated $4.81M.
- 88 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2023, down from 89 in Q3 2023.
- Funds reported $97.1M of Gritstone bio, Inc. Common Stock stock for Q4 2023, up 16% quarter-over-quarter.
- 13 funds opened new Gritstone bio, Inc. Common Stock positions in Q4 2023 and 14 closed out, a net change of -1 holder.
- The largest Gritstone bio, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $16.9M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q4 2023 was Redmile Group, an estimated $4.81M sold.
Based on aggregated 13F filings for Q4 2023.